Positive Programmed Cell Death-Ligand 1 Expression Predicts Poor Treatment Outcomes in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy

Background: Programmed cell death-ligand 1 (PD-L1) is present in a subgroup of cancer patients who may be favorable targets for immune checkpoint inhibitor therapies. However, the significance of the PD-L1 expression in esophageal squamous cell carcinoma (ESCC) patients receiving neoadjuvant chemora...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wan-Ting, Lu, Hung-I, Wang, Yu-Ming, Chen, Yen-Hao, Lo, Chien-Ming, Lin, Wei-Che, Lan, Ya-Chun, Tseng, Ling-Huei, Li, Shau-Hsuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912507/
https://www.ncbi.nlm.nih.gov/pubmed/31684197
http://dx.doi.org/10.3390/jcm8111864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912507/
https://www.ncbi.nlm.nih.gov/pubmed/31684197
http://dx.doi.org/10.3390/jcm8111864

Ejemplares similares